Decoding the Molecular Basis of Biased Signalling at CB2 to Enable Rational Design of Next-Generation GPCR Ligands
10:45 am - Wednesday 3rd March 2027
- Characterizing the molecular determinants of biased signalling at the CB2 receptor
- Linking receptor conformational states to functional signalling outcomes to better understand GPCR ligand efficacy
- Leveraging mechanistic insights to support the rational design of GPCR ligands with desired pharmacological profiles
